bg-img01

Provoking a sea change in immunotherapy.

go down
Our Science & Technologies

Our Difference

Hookipa’s proprietary TheraT® and Vaxwave® platforms have the potential to provide unprecedented cancer therapies and infectious disease vaccines.

TheraT® and Vaxwave® have shown promising abilities to deliver not only high antibody responses, but also necessary levels of T cell responses, currently missing in most vaccine and therapeutic approaches. Hookipa’s vectors can also be administered multiple times providing even greater immune protection.

We are looking forward to Phase 1 results with Vaxwave® in cytomegalovirus (CMV) and finalizing clinical plans for TheraT® in Human Papilloma Virus (HPV)- related head and neck cancers.

Every day we live and breathe to find ways of preventing or eradicating the most aggressive cancers and infectious diseases.

ico01

TheraT®

A safe attenuated replicating virus to combat cancer as a single agent or in combination with other therapies.

Our Work

Pipeline

Hookipa is committed to responsibly developing critical programs where TheraT® and Vaxwave® can make the biggest difference for the most people. Our science and technologies have demonstrated the possibility of highly potent antibody and T cell responses while maintaining safety, even with repeated administrations.

Compound Phase
HB-101 Vaxwave® 1
HB-201 TheraT® 1
HB-301 DISC
HB-401 DISC

Scientific advisory board

bg-img02
How to work with us

Partnering

Hookipa Biotech is committed to responsibly developing critical programs where TheraT® and Vaxwave® can make the biggest difference for the most people.

Hookipa Biotech is dedicated to utilizing the full potential of its two product platforms Vaxwave® and TheraT®. Vaxwave® is focused on the development of prophylactic vaccines to prevent infectious diseases and TheraT® enables Hookipa to develop immuno-oncology therapies and therapeutic vaccines.

We are open for strategic partnerships based on both platforms which reflect the potential of the technology, provide performance related downstream revenues while preserving growth opportunities for Hookipa Biotech in the future.

We look forward to hearing from you!

PARTNER WITH US
Presenting our team

Leadership

Hookipa is a dedicated team united by the desire to find solutions for people with untreatable cancers and infectious diseases. Our leadership brings together significant achievements in immunology and building successful biotech companies to demand the kind of innovation necessary to make things happen.

Executives
Who we work with

Investors